The modified Tyrodes solution contained in millimolar concentrations (mM): 119.8 NaCI, 5.4 KCI, 1.8 CaCl 2 , 1.05 MgCl 2 , 0.42 NaH 2 PO 4 , 22.6 NaHCO 3 , 0.05 Na 2 EDTA, 0.28 ascorbic acid, and 5.05 glucose
Blood flow is excellent
The levels of low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, and triglycerides were also decreased compared to placebo, which did not improve lipid profile
Garcia-Webb explains
This allows for comprehensive medication review, assessment of potential interactions with other medications, and appropriate monitoring
You can read the abstract of this article at LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial PubMed (nih.gov)